We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIR
RNS Number : 0578V
Circassia Pharmaceuticals Plc
18 July 2018
18 July 2018
Circassia Pharmaceuticals plc
Issue of Equity and Total Voting Rights
Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) announces that, further to the announcement made on 16(th) July 2018, 23,725,800 Ordinary Shares have been admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities (together, "Admission").
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia confirms that the Company's issued share capital consists of 357,192,062 Ordinary Shares, each with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Circassia Pharmaceuticals plc
Julien Cotta, Company Secretary +44 (0) 1865 405560
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCEAAXPFSFPEFF
(END) Dow Jones Newswires
July 18, 2018 08:52 ET (12:52 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions